Form D · Biotechnology
Iyuda Therapeutics, Inc.
Owings Mills, MD · CIK 0001993594
Offering snapshot reported Apr 6, 2026 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2026 | Initial | $599,999 | No comparison | 2 | SEC filing |
| Jun 6, 2025 | Amendment | $1,312,337 | $359,999vs Oct 21, 2024 | 3 | SEC filing |
| Oct 21, 2024 | Initial | $952,338 | No comparison | 3 | SEC filing |
| Sep 14, 2023 | Initial | $899,980 | No comparison | 1 | SEC filing |
| Sep 14, 2023 | Initial | $1,385,262 | No comparison | 1 | SEC filing |
| Sep 14, 2023 | Initial | $342,722 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-579207
Source: Form D, filed Apr 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ephraim Fuchs | Director |
| Robert Tennant | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3217 Hunting Tweed Dr.
Owings Mills, MD, 21117
Owings Mills, MD, 21117